| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-12 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-12 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.85 | 4e-09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.7 | 2e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |